Resource Library

The End of Chevron Deference: What it Means for Medtech

We hope you found our recent webinar on the Supreme Court’s decision in Relentless v. Department of Commerce and Loper Bright Enterprises v. Raimondo both informative and insightful. This landmark ruling, which overrules the doctrine of “Chevron deference,” will undoubtedly have a significant impact on the medtech industry and all regulated sectors for years to come.

For those who couldn’t attend live or wish to revisit the discussion, you can access the webinar recording and slide deck below.

Webinar Recording